SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining momentum as investors react to a series of strategic milestones, including expanded partnerships with U.S. Department of Energy national labs and a high-profile presence at the NVIDIA GTC conference. Community sentiment is deeply divided between long-term believers who are aggressively accumulating shares due to the company's defense-focused quantum hardware, and skeptics who are wary of recent downward price action following the company's de-SPAC process.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana is attracting attention due to a combination of persistent insider buying from the CEO and a potential turnaround narrative following a recent leadership transition. While some investors view the stock's discounted valuation and insider activity as a strong signal for a rebound, others remain skeptical, citing ongoing profitability challenges and intense competition from AI-integrated enterprise software.

Tria is a self-custodial neobank and cross-chain payments infrastructure designed to make onchain money usable in everyday life. It combines card spending, trading, and earning in a single account experience, so users can move value across chains without manually bridging assets, switching networks, or managing chain-specific steps. Under the hood, Tria routes every action through BestPath, an ultra-fast routing and execution layer that takes an intent like “spend,” “swap,” “send,” or “earn” and completes it end-to-end on the optimal path. Tria operates in two modes: a consumer app that includes a Visa-powered card, spot swaps, perpetual futures, and Earn vaults, and a developer and institutional layer that integrates with protocols and ecosystems to embed Tria’s execution rails wherever value already moves. The end goal is simple: one continuous flow for money across chains, with self-custody by default and a product experience that feels effortless for normal users worldwide.

TRIA

TRIA is gaining momentum as investors highlight its rapid user growth and real-world utility as a self-custodial neobank, while anticipation builds around potential upcoming partnerships with major online banks. The community is actively discussing its strong trading volumes and consistent chart consolidation, viewing the project as a unique, profitable player in the evolving blockchain financial space.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is in the spotlight as investors process strong second-quarter earnings that topped expectations, leading the company to raise its full-year guidance even as the defense sector faces ongoing scrutiny over executive compensation and capital allocation policies. The community is actively debating the impact of increased military spending priorities against recent regulatory pressures that threaten to limit dividends and buybacks for major defense contractors.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending as investors weigh strong earnings and capital return strategies against legal risks and broader sector concerns about credit quality. The community is actively discussing the bank's aggressive branch expansion, its stance on private credit stress, and the impact of ongoing regulatory and legal scrutiny on its long-term outlook.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae ($FNMA) is trending as investors digest a mix of regulatory uncertainty, potential legislative developments, and high-profile institutional interest from figures like Bill Ackman and Michael Burry. The community is actively debating the likelihood of an end to government conservatorship and an eventual uplisting to the NYSE, with sentiment sharply divided between long-term holders expecting a massive valuation reset and skeptics concerned about government delays and ongoing policy inertia.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) remains a focal point as investors grapple with extreme geopolitical risk and supply disruptions in the Strait of Hormuz, driving crude oil toward historic highs. Community sentiment is deeply divided between traders capitalizing on the energy-sector rotation and those bracing for the broader economic damage a sustained oil shock could inflict on the S&P 500.

Global X Funds - Global X Uranium ETF

Global X Uranium ETF

The uranium sector is currently oscillating between strong long-term fundamental demanddriven by AI data center energy needs and government push for nuclear independenceand short-term volatility stemming from corrective technical structures. While community sentiment remains largely bullish, investors are actively debating whether to buy current pullbacks or await further consolidation as the ETF navigates a complex macro environment.

Global X Funds - Global X Copper Miners ETF

The community is closely watching the Global X Copper Miners ETF ($COPX) as investors debate whether recent volatility represents a healthy accumulation period before a structural bull market or a deeper correction linked to broader economic jitters. While some traders are expressing frustration over recent price weakness, many remain focused on a long-term bullish thesis driven by supply-side deficits and the critical role copper plays in AI infrastructure, defense, and grid modernization.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is facing intense market volatility as investors weigh the stock's recent price depreciation against strong long-term fundamentals and growing enterprise demand for AI-integrated Zero Trust security. While the community remains sharply divided, with some traders citing 'AI disruption' fears and heavy short interest as catalysts for the downward trend, others are actively viewing these levels as an institutional accumulation opportunity ahead of upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Biotech Stocks To Follow Today - March 17th

Vertex Pharmaceuticals, bioAffinity Technologies, Lunai Bioworks, Danaher, Moderna, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Small Caps Surge on Breakouts, Biotech Validation, and “Real-World” Tech Adoption

Momentum is building across small-cap names this week, with a mix of technical breakouts, clinical validation, and commercialization milestones driving a more constructive tone beneath the surface of the market. $LNAI, $BIAF, $IBRX, $KBLB, $UCAR, $LIDR, $JTAI, $FLYX

<ul class="summary-bullets"><li>BioAffinity tested CyPath Lung on a 71-year-old former smoker with multiple lung nodules.</li><li>The non-invasive test confirmed that the lung nodules were likely due to inflammation rather than cancer.</li><li>CyPath Lung test uses advanced testing and artificial intelligence to analyze cells in a patient’s sputum.</li></ul>Shares of BioAffinity Technologies (BIAF) popped nearly 40% on Tuesday, after the biotech company shared a positive update from a new case study evaluating its non-invasive CyPath Lung test in evaluating lung cancer risk.BioAffinity used the CyPath Lung test on a 71-year-old former smoker with multiple lung nodules, a condition that often leads to invasive procedures.“In this case, the patient’s CyPath Lung result was negative, indicating a low likelihood of malignancy, and together both the patient and I were comfortable in waiting for a follow-up CT scan in three months,” said Daya Nadarajah, MD, the patient’s pulmonologist.Follow-up CT scans showed that the suspicious nodules had resolved, confirming they were likely due to inflammation rather than cancer. CyPath Lung test uses advanced testing and artificial intelligence to analyze cells in a patient’s sputum and detect signs that could suggest cancer.<h2 class="st-heading-2">Record CyPath Lung Revenue&nbsp;</h2>On March 13, 2026, BIAF shares closed 98% higher after the company reported an 87% increase in full-year (FY) 2025 revenue from CyPath Lung, with test volumes rising 99%.Its FY25 revenue fell to $6.2 million from $9.4 million in 2024, as it exited unprofitable services to focus on CyPath Lung. Net loss widened to $14.9 million, mainly due to higher clinical development costs, expanded sales efforts, and changes in warrant valuations.&nbsp;The company also raised $16.9 million to support growth. Looking ahead, it expects CyPath Lung unit sales to more than double in 2026, driving higher revenue.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/BIAF">BIAF</a> on Stocktwits has remained ‘extremely bullish’ over the past week, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/BIAF_jpg_6b2f0f777c.webp" alt="BIAF.jpg">One user said that trading in the stock is a “long term play.”<stembedurl>https://stocktwits.com/MicrocapCowboy/message/647734591</stembedurl>Another user expects the stock to breach its $3 resistance.<stembedurl>https://stocktwits.com/brallt/message/647730923</stembedurl>Around 100 million shares changed hands at the time of writing, well above the average of 0.3 million, according to Stocktwits data.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

Why Did BIAF Stock Surge 40% Today?

Shares of BioAffinity Technologies (BIAF) popped around 20% in pre-market trading on Tuesday, after the biotech company shared a positive update from a new case study evaluating its non-invasive CyPath Lung test in evaluating lung cancer risk.

Equity

The stock jumped on heavy volume after a positive update tied to its AI-driven lung cancer screening test.

Case Study Highlights How CyPath Lung Helps Patients Avoid Invasive Procedures

bioAffinity Technologies (NASDAQ:BIAF) released a new clinical case study demonstrating how its noninvasive diagnostic test, CyPath Lung, can help physicians make more confident decisions while sparing patients from unnecessary invasive procedures.

New Case Study: bioAffinity Technologies CyPath Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new clinical case study that...

Best Small Cap Stocks To Add to Your Watchlist - March 15th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, Direxion Daily PLTR Bear 1X Shares, Vale, and AltC Acquisition are the five Small Cap stocks to watch today, according to MarketBeat's...

Promising Biotech Stocks To Add to Your Watchlist - March 15th

Danaher, Vertex Pharmaceuticals, bioAffinity Technologies, Moderna, United Therapeutics, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Promising Small Cap Stocks To Consider - March 14th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, Direxion Daily PLTR Bear 1X Shares, Vale, AltC Acquisition, PAYP, and Direxion Daily AMD Bear 1X Shares are the seven Small Cap stocks to...

Biotech Stocks To Watch Now - March 14th

Danaher, Vertex Pharmaceuticals, and bioAffinity Technologies are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that...

Small Cap Stocks To Follow Today - March 13th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, and Direxion Daily PLTR Bear 1X Shares are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool...

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BIAF
BioAffinity Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BIAF News

BIAFBioAffinity Technologies Inc